Latest
An Unwavering Commitment to Quality and Transparency
Our resources are constantly expanding as we continue to develop innovative new methods that help our clients achieve therapeutic breakthroughs.
Whitepaper: CMC Guidelines for Breakthrough Therapy Drug Development, from Concept to Compliance
This whitepaper offers a critical roadmap for navigating the complexities of regulatory compliance in biologic therapy development. Highlighting innovative strategies
Whitepaper: Mitigating Risks in Oligonucleotide Therapeutic Development, Unlocking the Power of Sensitivity and Selectivity
Oligonucleotide therapies, including small interfering RNA (siRNA), microRNA (miRNA), and inhibitory antisense oligonucleotides (ASOs), have emerged as a promising group